Humoral theory of transplantation

被引:516
作者
Terasaki, PI [1 ]
机构
[1] Terasaki Fdn Lab, Los Angeles, CA USA
关键词
D O I
10.1034/j.1600-6143.2003.00135.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
According to the humoral theory of transplantation, antibodies cause allograft rejection. Publications are cited showing that antibodies: (1) cause hyperacute kidney rejection, (2) lead to C4d deposits associated with early kidney graft failures, (3) are a good indicator of presensitization leading to early acute rejections, (4) were present in 96% of 826 patients who rejected a kidney graft, (5) are associated with chronic rejection in 33 studies of kidney, heart, lung and liver grafts, and (6) in three studies, appeared in the circulation BEFORE evidence of bronchiolitis obliterans in lung transplants, and BEFORE kidney rejection. In addition, a prospective cooperative study of 1629 patients in 24 centers demonstrated that antibodies foretold subsequent failures after a follow-up period of 6 months (p=0.05). The specificity of antibodies detected in the serum of rejecting patients were often not donor specific,, presumably because they were absorbed by the rejecting organ. If the humoral theory is accepted, even provisionally, transplanted patients who have antibodies could be treated with immunosuppression until the antibodies disappear to determine whether chronic rejection can be blocked. If successful, in patients who do not have antibodies, immunosuppression could be reduced until antibodies appear.
引用
收藏
页码:665 / 673
页数:9
相关论文
共 126 条
[1]   Postoperative production of anti-donor antibody and chronic rejection in renal transplantation [J].
Abe, M ;
Kawai, T ;
Futatsuyama, K ;
Tanabe, K ;
Fuchinoue, S ;
Teraoka, S ;
Toma, H ;
Ota, K .
TRANSPLANTATION, 1997, 63 (11) :1616-1619
[2]   Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation [J].
Abou el Fettouh, H ;
Cook, DJ ;
Bishay, E ;
Flechner, S ;
Goldfarb, D ;
Modlin, C ;
Dennis, V ;
Novick, AC .
UROLOGY, 2000, 56 (03) :369-372
[3]   CHARACTERIZATION OF DONOR-DIRECTED ANTIBODY CLASS IN THE POSTTRANSPLANT PERIOD USING FLOW-CYTOMETRY IN RENAL-TRANSPLANTATION [J].
ALHUSSEIN, KA ;
SHENTON, BK ;
BELL, A ;
TALBOT, D ;
CLARK, KR ;
RIGG, KM ;
FORSYTHE, JLR ;
PROUD, G ;
TAYLOR, RMR .
TRANSPLANT INTERNATIONAL, 1994, 7 (03) :182-189
[4]   THE CLINICAL-SIGNIFICANCE OF POSTTRANSPLANTATION NON-HLA ANTIBODIES IN RENAL-TRANSPLANTATION [J].
ALHUSSEIN, KA ;
TALBOT, D ;
PROUD, G ;
TAYLOR, RMR ;
SHENTON, BK .
TRANSPLANT INTERNATIONAL, 1995, 8 (03) :214-220
[5]   Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: A case report [J].
Aranda, JM ;
Scornik, JC ;
Normann, SJ ;
Lottenberg, R ;
Schofield, RS ;
Pauly, DF ;
Miles, M ;
Hill, JA ;
Sleasman, JW ;
Skoda-Smith, S .
TRANSPLANTATION, 2002, 73 (06) :907-910
[6]  
BARR ML, 1993, TRANSPL P, V25, P262
[7]   Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies [J].
Behr, TM ;
Feucht, HE ;
Richter, K ;
Reiter, C ;
Spes, CH ;
Pongratz, D ;
Überfuhr, P ;
Meiser, B ;
Theisen, K ;
Angermann, CE .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09) :904-912
[8]   Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation [J].
Bian, H ;
Harris, PE ;
Reed, EF .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (09) :1315-1323
[9]   Is presensitization relevant to liver transplantation outcome? [J].
Bishara, A ;
Brautbar, C ;
Eid, A ;
Scherman, L ;
Ilan, Y ;
Safadi, R .
HUMAN IMMUNOLOGY, 2002, 63 (09) :742-750
[10]  
Bishay ES, 2000, TRANSPLANTATION, V70, P220